What are three key facts about cystic fibrosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: February 18, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What are the management and treatment options for cystic fibrosis?

What is the most appropriate action when a 7-year-old female with cystic fibrosis is playing with another child who also has cystic fibrosis?

What is the recommended course of action for a pregnant patient with advanced cystic fibrosis (CF) whose life is threatened by continuation of the pregnancy and is requesting an abortion?

What are the treatment options for individuals with CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) mutations?

What is the initial treatment approach for a patient admitted with cystic fibrosis?

Does subcutaneous haloperidol provide antipsychotic efficacy comparable to intramuscular or oral administration?

What are the typical transthoracic two-dimensional echocardiographic findings in a patient with rheumatic fever?

Can medico‑legal liability be presumed for a woman who suffered a perinatal asphyxial event when placenta accreta was identified only at cesarean delivery, subclinical pre‑eclampsia worsened postpartum, and an undifferentiated connective‑tissue disease was diagnosed postpartum, due to failure to diagnose these conditions in a timely manner?

What is the appropriate treatment for an adult patient with irritable bowel syndrome with constipation (IBS‑C)?

What are the benefits, dosing recommendations, and safety considerations of Trikafta (elexacaftor/tezacaftor/ivacaftor) for cystic fibrosis patients aged ≥ 2 years with at least one F508del mutation?

Can you ask me targeted questions to determine whether there were any warning signs or symptoms of placenta accreta spectrum, subclinical pre‑eclampsia, and undifferentiated connective‑tissue disease in the postpartum period?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.